Posts filed under ‘cost of healthcare’

Reference Pricing — Coming soon to a health plan near you?


There is great interest in reference pricing in the US for select medical procedures and branded drugs. While only 10% of mid-sized and large employers are utilizing reference pricing, more than 2/3 of employers have an interest in this payment technique. If it takes hold, there is a potential impact on utilization, revenue and quality of care that manufacturers will need to address.

Continue Reading November 11, 2015 at 6:00 PM Leave a comment

MedSpan Research Pay-For-Performance Case Study


MedSpan Research Pay-For-Performance Case Study http://wp.me/pReqv-m:

Connectivity is one of the Key Underlying P4P Programs…Read more to learn why

Continue Reading July 21, 2015 at 2:00 PM Leave a comment

Managed Care Musings-Tips for better payer research


Managed Care Musings-Tips for better payer research

Continue Reading July 21, 2015 at 12:33 PM Leave a comment

MedSpan Research’s Managed Markets Perspectives


MedSpan Research’s Managed Markets Perspectives: Pay For Performance Programs are becoming more prevalent. Dialysis facilities are already using this type of reimbursement program to improve on quality measures.

Continue Reading July 21, 2015 at 11:21 AM 1 comment

Here’s a MedSpan Research tip!


Clinical pharmacists are a good deal for drug companies’ market research. Consider clinical pharmacists as respondents when needing clinical insights regarding a new drug. Remember that health plan and some hospital-based clinical pharmacists specialize by drug class. Other hospital-based clinical pharmacists specialize by patient care unit (e.g., emergency department, ICU).

Continue Reading July 2, 2015 at 2:13 PM Leave a comment

Older Posts


Enter your email address to follow this blog and receive notifications of new posts by email.

Like this? Share it!

Share/Bookmark

Twitter Feed